Relapse Clinical Trial
— OrthRe10tionOfficial title:
A Single-center, 3-arm, Parallel-group Randomized Controlled Trial to Evaluate Bond Failures and the Effectiveness of Three Orthodontic Retention Schemes in Preventing Post-treatment Mandibular Arch Changes
There is high possibility of relapse of the lower anterior teeth after orthodontic treatment. Relapse is related with the initial orthodontic anomaly, pathology of surrounding tissues, patient's age and sex and compliance and the retention protocol applied. The options for the later are various. Permanent fixed retainers are considered of the most common ones and vastly vary based of composition. There are fixed retainers distinguished for their composition (SS, β-NiTi, fiber-reinforced composite retainers) or for their shape and dimensions (round or rectangular shape and single-strand or multi-strand respectively), and/or for the teeth they are placed on (canine and canine or canine to canine). Fixed retainers may require patient's cooperation , nevertheless debond failure rate varies between 0.1-53%. The aim of this prospective randomized clinical study is to compare failure incidents and retention effect on lower anterior teeth after orthodontic finish between three different types of fixed retainers. There will be 3 arms studied in this research: a) single strand 0.016x0.022'' β-Ti canine to canine, b) 0.028'' SS canine to canine and c) 0.027'' multi-strand twistflex canine to canine. Variables such as repeatability of failures, and undesired tooth movements will be measured. Measurements will be repeated every 3 months after patient's recruitment in this study, for one year period (12 months in total). Intraoral scans will be collected during baseline (fixed retainer insertion) and after 12 months.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | November 2024 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 13 Years to 30 Years |
Eligibility | Inclusion Criteria: - Patients treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) - Patients with fixed orthodontic appliances at least between their lower first premolars - No lower anterior teeth crowding (total irregularity index score = 0) - Patients with no need of removable retention appliances on their lower teeth Exclusion Criteria: - Active caries on adjacent or lingual surfaces of lower anterior teeth - Active periodontitis - Supragingival calculus - Gum bleeding during bonding of fixed retainer - Gingival pocket depth greater than 3mm - Syndromes or other anomalies of the craniofacial complex or other mental illness - Missing or impacted teeth or other dental anomalies - Congenital anomalies/syndromes - Allergies regarding the alloys of fixed retainers - Need for chemoprevention before data collection of periodontal indexes - Diabetes - Smoking - Usage of antibiotics - Pregnancy - Participation in other clinical trials |
Country | Name | City | State |
---|---|---|---|
Greece | National and Kapodistrian University of Athens, School of Dentistry, Departments of Orthodontics | Athens | Attiki |
Lead Sponsor | Collaborator |
---|---|
University of Athens |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of teeth that failed regarding the bonding strength | baseline-3 months | ||
Primary | Number of teeth that failed regarding the bonding strength | 3 months-6 months | ||
Primary | Number of teeth that failed regarding the bonding strength | 6 months-9 months | ||
Primary | Number of teeth that failed regarding the bonding strength | 9 months-1 year | ||
Primary | Repeatability of bonding strength failure per patient and per tooth | baseline-3 months | ||
Primary | Repeatability of bonding strength failure per patient and per tooth | 3 months-6 months | ||
Primary | Repeatability of bonding strength failure per patient and per tooth | 6 months-9months | ||
Primary | Repeatability of bonding strength failure per patient and per tooth | 9months-1 year | ||
Primary | Breakage of fixed retainer wires | baseline-3 months | ||
Primary | Breakage of fixed retainer wires | 3 months-6 months | ||
Primary | Breakage of fixed retainer wires | 6 months-9 months | ||
Primary | Breakage of fixed retainer wires | 9 months-1 year | ||
Primary | Space discrepancy (Little index)(in mm) | baseline-3 months | ||
Primary | Space discrepancy (Little index)(in mm) | 3 months-6 months | ||
Primary | Space discrepancy (Little index)(in mm) | 6 months-9 months | ||
Primary | Space discrepancy (Little index)(in mm) | 9 months-1 year | ||
Primary | Mandibular intercanine distance | baseline-3 months | ||
Primary | Mandibular intercanine distance | 3 months-6 months | ||
Primary | Mandibular intercanine distance | 6 months-9 months | ||
Primary | Mandibular arch length (in mm) | 9 months-1 year | ||
Secondary | Tooth rotations in lower anterior teeth | baseline-3 months | ||
Secondary | Tooth rotations in lower anterior teeth | 3 months-6 months | ||
Secondary | Tooth rotations in lower anterior teeth | 6 months-9 months | ||
Secondary | Tooth rotations in lower anterior teeth | 9 months-1 year | ||
Secondary | Extrusion in lower anterior teeth | baseline-3 months | ||
Secondary | Extrusion in lower anterior teeth | 3 months-6 months | ||
Secondary | Extrusion in lower anterior teeth | 6 months-9 months | ||
Secondary | Extrusion in lower anterior teeth | 9 months-1 year | ||
Secondary | Tip inclinations anteroposteriorly | baseline-3 months | ||
Secondary | Tip inclinations anteroposteriorly | 3 months-6 months | ||
Secondary | Tip inclinations anteroposteriorly | 6 months-9 months | ||
Secondary | Tip inclinations anteroposteriorly | 9 months -1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT00306813 -
Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma
|
Phase 1/Phase 2 | |
Completed |
NCT01956695 -
Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma
|
Phase 2 | |
Not yet recruiting |
NCT05926167 -
Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recovery
|
||
Recruiting |
NCT03710512 -
Evaluation of Early Relapse After Mandibular Lengthening Surgery
|
||
Recruiting |
NCT04921540 -
Ingrown Toenails : Surgery Only Versus Surgery + Chemical Cauterization With TCA
|
N/A | |
Not yet recruiting |
NCT03830827 -
MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users
|
Phase 4 | |
Completed |
NCT05250765 -
Comparison of Efficiency and Effectiveness of Two Types of Bonded Orthodontic Retainers: an RCT.
|
N/A | |
Completed |
NCT05915273 -
Relapse and Failure Rates Between CAD/CAM and Conventional Fixed Retainers
|
N/A | |
Active, not recruiting |
NCT04389879 -
CAD/CAM Fixed Retainers vs. Conventional Multistranded Fixed Retainers in Orthodontic Patients. Comparison of Stability, Retainer Failure Rate, Adverse Effects, Cost-effectiveness, and Patient Satisfaction. A Randomized Controlled Clinical Trial
|
N/A | |
Recruiting |
NCT06417346 -
Comparison of Laparoscopic and Open Inguinal Hernia Repair in Elderly Patients
|
N/A | |
Recruiting |
NCT06417359 -
Comparison of Mesh Fixation and Non-Fixation in eTEP
|
N/A | |
Completed |
NCT02145403 -
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
|
Phase 1/Phase 2 | |
Completed |
NCT01481701 -
A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma
|
Phase 2 | |
Recruiting |
NCT01941394 -
Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation
|
Phase 2 | |
Recruiting |
NCT04723901 -
Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04994626 -
Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies
|
Phase 2 | |
Recruiting |
NCT06292364 -
Comparison of Retention Characteristics of Immediate vs Delayed Retainer Delivery Using 3D Digital Model Analysis
|
N/A | |
Enrolling by invitation |
NCT05591703 -
Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
|
||
Active, not recruiting |
NCT00299923 -
Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy
|
Phase 3 |